Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNaproxen and Wegovy can generally be taken together, but there is a clinically meaningful reason to be careful. Semaglutide slows gastric emptying, which changes how your stomach handles anti-inflammatory medicines — and naproxen, taken on a stomach already under GI stress from treatment, raises the risk of irritation or ulceration. This is not a flat contraindication, but it is a conversation worth having with your prescriber before reaching for the ibuprofen alternative in your medicine cabinet. Wegovy is a prescription-only medicine requiring clinical assessment; the prescriber who reviews your treatment is best placed to weigh up your individual situation, including any regular pain relief you rely on.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
GLP-1 receptor agonists like semaglutide work partly by slowing the rate at which your stomach empties into the small intestine. The NHS patient information page for semaglutide notes that this gastric-slowing effect sits at the centre of how the medicine reduces appetite and lowers post-meal blood sugar spikes. The practical consequence for oral medicines is that they may sit in the stomach longer than usual before being absorbed.
For naproxen specifically, prolonged contact with the stomach lining is the concern. Naproxen is an NSAID (a non-steroidal anti-inflammatory drug) and NSAIDs are well-established irritants of the gastric mucosa. They inhibit prostaglandins that normally protect the stomach wall, which is why naproxen packaging advises taking it with food and why doctors are cautious about long-term NSAID use in anyone with a history of gastric ulcers. If semaglutide keeps the tablet in contact with the stomach lining for longer than it would otherwise be, that irritation window extends.
This does not mean a single naproxen tablet for a headache is dangerous. The concern scales with dose, frequency and your existing GI tolerance. Someone who takes naproxen twice daily for arthritis is in a different position from someone who takes it once after a minor injury. Your prescriber will factor in that pattern when reviewing your medication list.
A misconception worth clearing up: many people assume the only issue is a direct chemical interaction between naproxen and semaglutide in the bloodstream. There is not a strong pharmacokinetic interaction of that kind in the published data. The real risk is more indirect, and it runs through the kidneys.
Nausea and vomiting are among the most common side effects of Wegovy, particularly in the early weeks of treatment or after a dose increase. NHS England's guidance on weight-management injections specifically highlights dehydration as a risk when GI symptoms are significant. Naproxen, like all NSAIDs, reduces blood flow to the kidneys by inhibiting prostaglandins that keep renal vessels dilated. In a well-hydrated person this effect is modest and reversible. In someone who has been vomiting and is already mildly dehydrated, the same effect can push kidney function into territory that warrants monitoring.
Drinking plenty of water during treatment is genuinely important, not just comfort advice. If you are experiencing significant nausea or vomiting and have also taken naproxen, reduced urine output or swelling in your legs are signs to seek medical advice promptly. You can also explore how other supplements and medicines interact with Wegovy through our related guides.
The considerations above apply to most adults, but a few groups need to be particularly alert. Anyone with a prior history of peptic ulcers, gastritis, or GI bleeding should discuss NSAID use with their prescriber before starting semaglutide, not after. People with existing kidney disease or reduced kidney function are in the same category. The same applies if you are already taking a low-dose aspirin for cardiovascular protection, because combining two NSAIDs raises GI and renal risks further.
If you need pain relief regularly, paracetamol is generally a gentler choice during GLP-1 treatment, it does not share the gastric or renal risks of NSAIDs. Your GP or prescriber can advise on whether a proton pump inhibitor (a stomach-protecting medicine) would be appropriate if naproxen is genuinely necessary on an ongoing basis.
For a broader picture of what the clinical assessment for Wegovy covers, the eligibility and suitability overview is a useful starting point. Those exploring the wider semaglutide interaction picture may also find the naproxen and semaglutide guide helpful, since the active ingredient is identical to Wegovy's. If you are in the early stages of researching treatment and want to understand the full picture, our Wegovy overview covers mechanism, eligibility and what a supervised course involves. Questions about how long treatment typically continues come up often, too. Cost is a separate but fair question, our guide to Wegovy pricing in the UK sets out what private treatment typically involves without overpromising.
If you have a consultation with a nume prescriber, your full medication list (including over-the-counter painkillers you take regularly) is part of that review. A real clinician reads every submission on the same day it arrives; nothing is waved through by software. That review is where questions like this one get a personalised answer. Start your free consultation when you are ready.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.